F901318	B:C3896862
represents	O
a	O
novel	O
class	O
of	O
antifungal	O
drug	I:C0003308
that	O
inhibits	O
dihydroorotate	O
dehydrogenase	I:C0058099
.	O

F901318	O
represents	O
a	O
novel	O
class	B:C0456387
of	O
antifungal	O
drug	I:C0003308
that	O
inhibits	O
dihydroorotate	O
dehydrogenase	I:C0058099
.	O

F901318	O
represents	O
a	O
novel	O
class	O
of	O
antifungal	B:C0003308
drug	I:C0003308
that	O
inhibits	O
dihydroorotate	O
dehydrogenase	I:C0058099
.	O

F901318	O
represents	O
a	O
novel	O
class	O
of	O
antifungal	O
drug	I:C0003308
that	O
inhibits	O
dihydroorotate	B:C0058099
dehydrogenase	I:C0058099
.	O

There	O
is	O
an	O
important	O
medical	O
need	O
for	O
new	O
antifungal	B:C0003308
agents	I:C0003308
with	O
novel	O
mechanisms	O
of	O
action	O
to	O
treat	O
the	O
increasing	O
number	O
of	I:C2360800
patients	I:C2360800
with	O
life	O
-	I:C2826244
threatening	I:C2826244
systemic	O
fungal	I:C0553576
disease	I:C0553576
and	O
to	O
overcome	O
the	O
growing	O
problem	O
of	O
resistance	O
to	O
current	O
therapies	I:C2827774
.	O

There	O
is	O
an	O
important	O
medical	O
need	O
for	O
new	O
antifungal	O
agents	I:C0003308
with	O
novel	O
mechanisms	O
of	O
action	O
to	O
treat	B:C0087111
the	O
increasing	O
number	O
of	I:C2360800
patients	I:C2360800
with	O
life	O
-	I:C2826244
threatening	I:C2826244
systemic	O
fungal	I:C0553576
disease	I:C0553576
and	O
to	O
overcome	O
the	O
growing	O
problem	O
of	O
resistance	O
to	O
current	O
therapies	I:C2827774
.	O

There	O
is	O
an	O
important	O
medical	O
need	O
for	O
new	O
antifungal	O
agents	I:C0003308
with	O
novel	O
mechanisms	O
of	O
action	O
to	O
treat	O
the	O
increasing	O
number	B:C2360800
of	I:C2360800
patients	I:C2360800
with	O
life	O
-	I:C2826244
threatening	I:C2826244
systemic	O
fungal	I:C0553576
disease	I:C0553576
and	O
to	O
overcome	O
the	O
growing	O
problem	O
of	O
resistance	O
to	O
current	O
therapies	I:C2827774
.	O

There	O
is	O
an	O
important	O
medical	O
need	O
for	O
new	O
antifungal	O
agents	I:C0003308
with	O
novel	O
mechanisms	O
of	O
action	O
to	O
treat	O
the	O
increasing	O
number	O
of	I:C2360800
patients	I:C2360800
with	O
life	B:C2826244
-	I:C2826244
threatening	I:C2826244
systemic	O
fungal	I:C0553576
disease	I:C0553576
and	O
to	O
overcome	O
the	O
growing	O
problem	O
of	O
resistance	O
to	O
current	O
therapies	I:C2827774
.	O

There	O
is	O
an	O
important	O
medical	O
need	O
for	O
new	O
antifungal	O
agents	I:C0003308
with	O
novel	O
mechanisms	O
of	O
action	O
to	O
treat	O
the	O
increasing	O
number	O
of	I:C2360800
patients	I:C2360800
with	O
life	O
-	I:C2826244
threatening	I:C2826244
systemic	B:C0553576
fungal	I:C0553576
disease	I:C0553576
and	O
to	O
overcome	O
the	O
growing	O
problem	O
of	O
resistance	O
to	O
current	O
therapies	I:C2827774
.	O

There	O
is	O
an	O
important	O
medical	O
need	O
for	O
new	O
antifungal	O
agents	I:C0003308
with	O
novel	O
mechanisms	O
of	O
action	O
to	O
treat	O
the	O
increasing	O
number	O
of	I:C2360800
patients	I:C2360800
with	O
life	O
-	I:C2826244
threatening	I:C2826244
systemic	O
fungal	I:C0553576
disease	I:C0553576
and	O
to	O
overcome	O
the	O
growing	O
problem	B:C0033213
of	O
resistance	O
to	O
current	O
therapies	I:C2827774
.	O

There	O
is	O
an	O
important	O
medical	O
need	O
for	O
new	O
antifungal	O
agents	I:C0003308
with	O
novel	O
mechanisms	O
of	O
action	O
to	O
treat	O
the	O
increasing	O
number	O
of	I:C2360800
patients	I:C2360800
with	O
life	O
-	I:C2826244
threatening	I:C2826244
systemic	O
fungal	I:C0553576
disease	I:C0553576
and	O
to	O
overcome	O
the	O
growing	O
problem	O
of	O
resistance	B:C1514892
to	O
current	O
therapies	I:C2827774
.	O

There	O
is	O
an	O
important	O
medical	O
need	O
for	O
new	O
antifungal	O
agents	I:C0003308
with	O
novel	O
mechanisms	O
of	O
action	O
to	O
treat	O
the	O
increasing	O
number	O
of	I:C2360800
patients	I:C2360800
with	O
life	O
-	I:C2826244
threatening	I:C2826244
systemic	O
fungal	I:C0553576
disease	I:C0553576
and	O
to	O
overcome	O
the	O
growing	O
problem	O
of	O
resistance	O
to	O
current	B:C2827774
therapies	I:C2827774
.	O

F901318	B:C3896862
,	O
the	O
leading	O
representative	O
of	O
a	O
novel	O
class	O
of	O
drug	O
,	O
the	O
orotomides	O
,	O
is	O
an	O
antifungal	O
drug	I:C0003308
in	O
clinical	O
development	I:C1512068
that	O
demonstrates	O
excellent	O
potency	O
against	O
a	O
broad	O
range	O
of	O
dimorphic	O
and	O
filamentous	O
fungi	I:C0369241
.	O

F901318	O
,	O
the	O
leading	O
representative	O
of	O
a	O
novel	O
class	B:C0456387
of	O
drug	O
,	O
the	O
orotomides	O
,	O
is	O
an	O
antifungal	O
drug	I:C0003308
in	O
clinical	O
development	I:C1512068
that	O
demonstrates	O
excellent	O
potency	O
against	O
a	O
broad	O
range	O
of	O
dimorphic	O
and	O
filamentous	O
fungi	I:C0369241
.	O

F901318	O
,	O
the	O
leading	O
representative	O
of	O
a	O
novel	O
class	O
of	O
drug	B:C1254351
,	O
the	O
orotomides	O
,	O
is	O
an	O
antifungal	O
drug	I:C0003308
in	O
clinical	O
development	I:C1512068
that	O
demonstrates	O
excellent	O
potency	O
against	O
a	O
broad	O
range	O
of	O
dimorphic	O
and	O
filamentous	O
fungi	I:C0369241
.	O

F901318	O
,	O
the	O
leading	O
representative	O
of	O
a	O
novel	O
class	O
of	O
drug	O
,	O
the	O
orotomides	B:C1254351
,	O
is	O
an	O
antifungal	O
drug	I:C0003308
in	O
clinical	O
development	I:C1512068
that	O
demonstrates	O
excellent	O
potency	O
against	O
a	O
broad	O
range	O
of	O
dimorphic	O
and	O
filamentous	O
fungi	I:C0369241
.	O

F901318	O
,	O
the	O
leading	O
representative	O
of	O
a	O
novel	O
class	O
of	O
drug	O
,	O
the	O
orotomides	O
,	O
is	O
an	O
antifungal	B:C0003308
drug	I:C0003308
in	O
clinical	O
development	I:C1512068
that	O
demonstrates	O
excellent	O
potency	O
against	O
a	O
broad	O
range	O
of	O
dimorphic	O
and	O
filamentous	O
fungi	I:C0369241
.	O

F901318	O
,	O
the	O
leading	O
representative	O
of	O
a	O
novel	O
class	O
of	O
drug	O
,	O
the	O
orotomides	O
,	O
is	O
an	O
antifungal	O
drug	I:C0003308
in	O
clinical	B:C1512068
development	I:C1512068
that	O
demonstrates	O
excellent	O
potency	O
against	O
a	O
broad	O
range	O
of	O
dimorphic	O
and	O
filamentous	O
fungi	I:C0369241
.	O

F901318	O
,	O
the	O
leading	O
representative	O
of	O
a	O
novel	O
class	O
of	O
drug	O
,	O
the	O
orotomides	O
,	O
is	O
an	O
antifungal	O
drug	I:C0003308
in	O
clinical	O
development	I:C1512068
that	O
demonstrates	O
excellent	O
potency	O
against	O
a	O
broad	O
range	O
of	O
dimorphic	B:C1562222
and	O
filamentous	O
fungi	I:C0369241
.	O

F901318	O
,	O
the	O
leading	O
representative	O
of	O
a	O
novel	O
class	O
of	O
drug	O
,	O
the	O
orotomides	O
,	O
is	O
an	O
antifungal	O
drug	I:C0003308
in	O
clinical	O
development	I:C1512068
that	O
demonstrates	O
excellent	O
potency	O
against	O
a	O
broad	O
range	O
of	O
dimorphic	O
and	O
filamentous	B:C0369241
fungi	I:C0369241
.	O

In	O
vitro	O
susceptibility	B:C0806957
testing	I:C0806957
of	O
F901318	O
against	O
more	O
than	O
100	O
strains	O
from	O
the	O
four	O
main	O
pathogenic	O
Aspergillus	O
spp.	I:C0004034
revealed	O
minimal	O
inhibitory	I:C1304747
concentrations	I:C1304747
of	O
≤	O
0.06	O
µg	O
/	O
mL-	O
greater	O
potency	O
than	O
the	O
leading	O
antifungal	O
classes	O
.	O

In	O
vitro	O
susceptibility	O
testing	I:C0806957
of	O
F901318	B:C3896862
against	O
more	O
than	O
100	O
strains	O
from	O
the	O
four	O
main	O
pathogenic	O
Aspergillus	O
spp.	I:C0004034
revealed	O
minimal	O
inhibitory	I:C1304747
concentrations	I:C1304747
of	O
≤	O
0.06	O
µg	O
/	O
mL-	O
greater	O
potency	O
than	O
the	O
leading	O
antifungal	O
classes	O
.	O

In	O
vitro	O
susceptibility	O
testing	I:C0806957
of	O
F901318	O
against	O
more	O
than	O
100	O
strains	O
from	O
the	O
four	O
main	O
pathogenic	O
Aspergillus	B:C0004034
spp.	I:C0004034
revealed	O
minimal	O
inhibitory	I:C1304747
concentrations	I:C1304747
of	O
≤	O
0.06	O
µg	O
/	O
mL-	O
greater	O
potency	O
than	O
the	O
leading	O
antifungal	O
classes	O
.	O

In	O
vitro	O
susceptibility	O
testing	I:C0806957
of	O
F901318	O
against	O
more	O
than	O
100	O
strains	O
from	O
the	O
four	O
main	O
pathogenic	O
Aspergillus	O
spp.	I:C0004034
revealed	O
minimal	B:C1304747
inhibitory	I:C1304747
concentrations	I:C1304747
of	O
≤	O
0.06	O
µg	O
/	O
mL-	O
greater	O
potency	O
than	O
the	O
leading	O
antifungal	O
classes	O
.	O

In	O
vitro	O
susceptibility	O
testing	I:C0806957
of	O
F901318	O
against	O
more	O
than	O
100	O
strains	O
from	O
the	O
four	O
main	O
pathogenic	O
Aspergillus	O
spp.	I:C0004034
revealed	O
minimal	O
inhibitory	I:C1304747
concentrations	I:C1304747
of	O
≤	O
0.06	O
µg	O
/	O
mL-	O
greater	O
potency	O
than	O
the	O
leading	O
antifungal	B:C0003235
classes	O
.	O

In	O
vitro	O
susceptibility	O
testing	I:C0806957
of	O
F901318	O
against	O
more	O
than	O
100	O
strains	O
from	O
the	O
four	O
main	O
pathogenic	O
Aspergillus	O
spp.	I:C0004034
revealed	O
minimal	O
inhibitory	I:C1304747
concentrations	I:C1304747
of	O
≤	O
0.06	O
µg	O
/	O
mL-	O
greater	O
potency	O
than	O
the	O
leading	O
antifungal	O
classes	B:C0456387
.	O

An	O
investigation	B:C0220825
into	O
the	O
mechanism	O
of	O
action	O
of	O
F901318	O
found	O
that	O
it	O
acts	O
via	O
inhibition	O
of	O
the	O
pyrimidine	O
biosynthesis	O
enzyme	O
dihydroorotate	I:C0058099
dehydrogenase	I:C0058099
(	O
dihydroorotate	O
dehydrogenase	I:C0058099
)	O
in	O
a	O
fungal	O
-	O
specific	O
manner	O
.	O

An	O
investigation	O
into	O
the	O
mechanism	O
of	O
action	O
of	O
F901318	B:C3896862
found	O
that	O
it	O
acts	O
via	O
inhibition	O
of	O
the	O
pyrimidine	O
biosynthesis	O
enzyme	O
dihydroorotate	I:C0058099
dehydrogenase	I:C0058099
(	O
dihydroorotate	O
dehydrogenase	I:C0058099
)	O
in	O
a	O
fungal	O
-	O
specific	O
manner	O
.	O

An	O
investigation	O
into	O
the	O
mechanism	O
of	O
action	O
of	O
F901318	O
found	O
that	O
it	O
acts	O
via	O
inhibition	O
of	O
the	O
pyrimidine	B:C0034289
biosynthesis	O
enzyme	O
dihydroorotate	I:C0058099
dehydrogenase	I:C0058099
(	O
dihydroorotate	O
dehydrogenase	I:C0058099
)	O
in	O
a	O
fungal	O
-	O
specific	O
manner	O
.	O

An	O
investigation	O
into	O
the	O
mechanism	O
of	O
action	O
of	O
F901318	O
found	O
that	O
it	O
acts	O
via	O
inhibition	O
of	O
the	O
pyrimidine	O
biosynthesis	O
enzyme	B:C0058099
dihydroorotate	I:C0058099
dehydrogenase	I:C0058099
(	O
dihydroorotate	O
dehydrogenase	I:C0058099
)	O
in	O
a	O
fungal	O
-	O
specific	O
manner	O
.	O

An	O
investigation	O
into	O
the	O
mechanism	O
of	O
action	O
of	O
F901318	O
found	O
that	O
it	O
acts	O
via	O
inhibition	O
of	O
the	O
pyrimidine	O
biosynthesis	O
enzyme	O
dihydroorotate	I:C0058099
dehydrogenase	I:C0058099
(	O
dihydroorotate	B:C0058099
dehydrogenase	I:C0058099
)	O
in	O
a	O
fungal	O
-	O
specific	O
manner	O
.	O

An	O
investigation	O
into	O
the	O
mechanism	O
of	O
action	O
of	O
F901318	O
found	O
that	O
it	O
acts	O
via	O
inhibition	O
of	O
the	O
pyrimidine	O
biosynthesis	O
enzyme	O
dihydroorotate	I:C0058099
dehydrogenase	I:C0058099
(	O
dihydroorotate	O
dehydrogenase	I:C0058099
)	O
in	O
a	O
fungal	B:C0016832
-	O
specific	O
manner	O
.	O

Homology	B:C1512489
modeling	I:C1512489
of	O
Aspergillus	O
fumigatus	I:C0004037
dihydroorotate	O
dehydrogenase	I:C0058099
has	O
identified	O
a	O
predicted	O
binding	O
mode	O
of	O
the	O
inhibitor	O
and	O
important	O
interacting	O
amino	O
acid	I:C0002520
residues	I:C0002520
.	O

Homology	O
modeling	I:C1512489
of	O
Aspergillus	B:C0004037
fumigatus	I:C0004037
dihydroorotate	O
dehydrogenase	I:C0058099
has	O
identified	O
a	O
predicted	O
binding	O
mode	O
of	O
the	O
inhibitor	O
and	O
important	O
interacting	O
amino	O
acid	I:C0002520
residues	I:C0002520
.	O

Homology	O
modeling	I:C1512489
of	O
Aspergillus	O
fumigatus	I:C0004037
dihydroorotate	B:C0058099
dehydrogenase	I:C0058099
has	O
identified	O
a	O
predicted	O
binding	O
mode	O
of	O
the	O
inhibitor	O
and	O
important	O
interacting	O
amino	O
acid	I:C0002520
residues	I:C0002520
.	O

Homology	O
modeling	I:C1512489
of	O
Aspergillus	O
fumigatus	I:C0004037
dihydroorotate	O
dehydrogenase	I:C0058099
has	O
identified	O
a	O
predicted	O
binding	O
mode	O
of	O
the	O
inhibitor	O
and	O
important	O
interacting	O
amino	B:C0002520
acid	I:C0002520
residues	I:C0002520
.	O

In	O
a	O
murine	B:C0026809
pulmonary	O
model	O
of	O
aspergillosis	O
,	O
F901318	O
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	O
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	B:C0024109
model	O
of	O
aspergillosis	O
,	O
F901318	O
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	O
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	O
model	O
of	O
aspergillosis	B:C0004030
,	O
F901318	O
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	O
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	O
model	O
of	O
aspergillosis	O
,	O
F901318	B:C3896862
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	O
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	O
model	O
of	O
aspergillosis	O
,	O
F901318	O
displays	O
in	B:C1515655
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	O
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	O
model	O
of	O
aspergillosis	O
,	O
F901318	O
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	B:C0004037
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	O
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	O
model	O
of	O
aspergillosis	O
,	O
F901318	O
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	B:C0004504
class	O
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	O
model	O
of	O
aspergillosis	O
,	O
F901318	O
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	B:C0456387
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	O
model	O
of	O
aspergillosis	O
,	O
F901318	O
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	O
of	O
antifungals	B:C0003235
and	O
a	O
strain	O
displaying	O
an	O
azole	O
-	O
resistant	O
phenotype	O
.	O

In	O
a	O
murine	O
pulmonary	O
model	O
of	O
aspergillosis	O
,	O
F901318	O
displays	O
in	O
vivo	I:C1515655
efficacy	O
against	O
a	O
strain	O
of	O
A.	O
fumigatus	I:C0004037
sensitive	O
to	O
the	O
azole	O
class	O
of	O
antifungals	O
and	O
a	O
strain	O
displaying	O
an	O
azole	B:C0004504
-	O
resistant	O
phenotype	O
.	O

F901318	B:C3896862
is	O
currently	O
in	O
late	O
Phase	O
1	O
clinical	O
trials	I:C0008976
,	O
offering	O
hope	O
that	O
the	O
antifungal	O
armamentarium	O
can	O
be	O
expanded	O
to	O
include	O
a	O
class	O
of	O
agent	O
with	O
a	O
mechanism	O
of	O
action	O
distinct	O
from	O
currently	O
marketed	O
antifungals	O
.	O

F901318	O
is	O
currently	O
in	O
late	O
Phase	O
1	O
clinical	B:C0008976
trials	I:C0008976
,	O
offering	O
hope	O
that	O
the	O
antifungal	O
armamentarium	O
can	O
be	O
expanded	O
to	O
include	O
a	O
class	O
of	O
agent	O
with	O
a	O
mechanism	O
of	O
action	O
distinct	O
from	O
currently	O
marketed	O
antifungals	O
.	O

F901318	O
is	O
currently	O
in	O
late	O
Phase	O
1	O
clinical	O
trials	I:C0008976
,	O
offering	O
hope	O
that	O
the	O
antifungal	B:C0003235
armamentarium	O
can	O
be	O
expanded	O
to	O
include	O
a	O
class	O
of	O
agent	O
with	O
a	O
mechanism	O
of	O
action	O
distinct	O
from	O
currently	O
marketed	O
antifungals	O
.	O

F901318	O
is	O
currently	O
in	O
late	O
Phase	O
1	O
clinical	O
trials	I:C0008976
,	O
offering	O
hope	O
that	O
the	O
antifungal	O
armamentarium	O
can	O
be	O
expanded	B:C0205229
to	O
include	O
a	O
class	O
of	O
agent	O
with	O
a	O
mechanism	O
of	O
action	O
distinct	O
from	O
currently	O
marketed	O
antifungals	O
.	O

F901318	O
is	O
currently	O
in	O
late	O
Phase	O
1	O
clinical	O
trials	I:C0008976
,	O
offering	O
hope	O
that	O
the	O
antifungal	O
armamentarium	O
can	O
be	O
expanded	O
to	O
include	O
a	O
class	B:C0456387
of	O
agent	O
with	O
a	O
mechanism	O
of	O
action	O
distinct	O
from	O
currently	O
marketed	O
antifungals	O
.	O

F901318	O
is	O
currently	O
in	O
late	O
Phase	O
1	O
clinical	O
trials	I:C0008976
,	O
offering	O
hope	O
that	O
the	O
antifungal	O
armamentarium	O
can	O
be	O
expanded	O
to	O
include	O
a	O
class	O
of	O
agent	B:C0003308
with	O
a	O
mechanism	O
of	O
action	O
distinct	O
from	O
currently	O
marketed	O
antifungals	O
.	O

F901318	O
is	O
currently	O
in	O
late	O
Phase	O
1	O
clinical	O
trials	I:C0008976
,	O
offering	O
hope	O
that	O
the	O
antifungal	O
armamentarium	O
can	O
be	O
expanded	O
to	O
include	O
a	O
class	O
of	O
agent	O
with	O
a	O
mechanism	O
of	O
action	O
distinct	O
from	O
currently	O
marketed	O
antifungals	B:C0003235
.	O

